What is the appropriate treatment for a patient experiencing a hypersensitivity reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hypersensitivity Reactions

Immediately administer intramuscular epinephrine 0.3-0.5 mg into the anterolateral thigh for any patient presenting with anaphylaxis, activate emergency medical services, and provide supportive care with oxygen and IV fluids as needed. 1, 2

Immediate Management of Anaphylaxis

Epinephrine is the only first-line treatment for anaphylaxis and must never be delayed or substituted with antihistamines or corticosteroids. 1, 3

  • Administer epinephrine 0.3-0.5 mg intramuscularly in the anterolateral thigh for adults (0.01 mg/kg for children, maximum 0.5 mg) 4, 1
  • Repeat epinephrine every 5-15 minutes if symptoms persist or recur 1
  • Call emergency medical services immediately after administering epinephrine, even if symptoms improve 4, 1
  • Place patient in supine position with legs elevated (if tolerated and no respiratory distress) 1
  • Provide supplemental oxygen to all patients with prolonged reactions, hypoxemia, or requiring multiple epinephrine doses 1
  • Establish IV access and administer normal saline for hypotension 1

Fatal anaphylaxis is associated with delayed or absent epinephrine administration—there are no contraindications to epinephrine use in life-threatening anaphylaxis, even in patients with cardiovascular disease or taking beta-blockers. 3

Adjunctive Therapies (Secondary to Epinephrine)

After epinephrine administration, adjunctive medications may be given but should never replace or delay epinephrine 1, 3:

  • H1-antihistamines (diphenhydramine 25-50 mg IV/IM or equivalent) for cutaneous symptoms 4, 1
  • H2-antihistamines (famotidine 20 mg IV or ranitidine 50 mg IV) may provide additional benefit 4
  • Corticosteroids (methylprednisolone 125 mg IV or hydrocortisone 200 mg IV) to potentially reduce biphasic reactions, though evidence is limited 4, 3
  • Bronchodilators (albuterol) for persistent bronchospasm despite epinephrine 1

Antihistamines and corticosteroids are NOT substitutes for epinephrine and have no role in preventing or treating the life-threatening manifestations of anaphylaxis. 3

Management of Mild-to-Moderate Hypersensitivity Reactions

Cutaneous-Only Reactions

For isolated cutaneous symptoms (urticaria, pruritus, mild angioedema) without respiratory, cardiovascular, or gastrointestinal involvement 4:

  • Initial treatment may include H1-antihistamines and close observation 4
  • Have epinephrine immediately available and monitor for progression to anaphylaxis 4
  • If symptoms progress beyond isolated cutaneous manifestations, immediately administer epinephrine 4, 1

Large Local Reactions (Insect Stings)

For extensive local swelling at sting sites 4:

  • Apply cold compresses to reduce pain and swelling 4
  • Administer oral antihistamines for pruritus 4
  • Consider short course of oral corticosteroids (prednisone 40-60 mg daily for 3-5 days) for severe local swelling 4
  • Antibiotics are usually not necessary as swelling is allergic inflammation, not infection 4

Drug-Specific Hypersensitivity Management

Chemotherapy Infusion Reactions

For platinum agents (carboplatin, cisplatin, oxaliplatin) and taxanes (paclitaxel, docetaxel): 4

First exposure (mild infusion reaction):

  • Decrease or stop infusion rate 4
  • Administer antihistamine 4
  • If vital signs remain stable and symptoms resolve quickly, may rechallenge with slower infusion 4
  • Premedicate with antihistamine, corticosteroids, and H2-blockers for subsequent infusions 4

Second or subsequent exposure with reaction:

  • Administer antihistamine for symptoms 4
  • Add corticosteroid ± IM epinephrine if symptoms do not quickly resolve 4
  • Do not rechallenge until evaluated by allergist 4
  • Consider desensitization protocol for subsequent infusions if drug is irreplaceable 4

Severe or life-threatening reactions:

  • Discontinue infusion immediately 4
  • Administer epinephrine, antihistamines, corticosteroids, and supportive care 4
  • Refer to center with desensitization expertise if drug is essential 4

Radiocontrast Media Reactions

For patients with history of severe immediate hypersensitivity to iodinated contrast media: 4, 5

  • First-line approach: Consider alternative non-contrast imaging (ultrasound, non-contrast CT, MRI without gadolinium) 5
  • If contrast-enhanced imaging is essential: Switch to a different low- or iso-osmolar contrast agent (more effective than premedication alone) 4, 5
  • Premedication (reserved for severe prior reactions when alternatives unavailable): Prednisone 50 mg at 13,7, and 1 hour before procedure PLUS diphenhydramine 50 mg 1 hour before procedure 5
  • Perform procedure in hospital setting with personnel and equipment immediately available to treat anaphylaxis 4, 5

Critical pitfall: Patients with shellfish/seafood allergies or iodine allergies do NOT require premedication for contrast media—these are not risk factors for contrast reactions 4, 5

Antibiotic Hypersensitivity

For penicillin-allergic patients requiring beta-lactam therapy: 4

  • Vancomycin may be substituted in patients with immediate-type hypersensitivity reactions to beta-lactams 4
  • Cefazolin may be used in patients with non-immediate-type hypersensitivity reactions to penicillins 4
  • Consider allergy consultation for skin testing and potential delabeling 4

Post-Reaction Management and Prevention

Immediate Post-Reaction Care

  • Transport all patients who received epinephrine to emergency department for monitoring (minimum 4-6 hours observation) 4, 1
  • Obtain serum tryptase level 30-120 minutes after reaction onset to confirm anaphylaxis 6
  • Prescribe epinephrine auto-injectors (two devices) for any patient with history of anaphylaxis 4, 1
  • Provide written anaphylaxis action plan 4, 1

Long-Term Management

  • Refer all patients with systemic reactions to allergist-immunologist for comprehensive evaluation 1
  • Perform skin testing 4-6 weeks after reaction to identify culprit agent and safe alternatives 6, 7
  • Consider venom immunotherapy for insect sting anaphylaxis (reduces future reaction risk from 25-70% to <5%) 4, 1
  • Educate patients on avoidance measures and proper epinephrine auto-injector technique 4, 1

Critical Pitfalls to Avoid

  • Never delay epinephrine in favor of antihistamines or corticosteroids for anaphylaxis 1, 3
  • Do not rely on premedication to prevent hypersensitivity reactions—it has very limited proven benefit (NNT 69-385 for most indications) and does not substitute for emergency preparedness 3
  • Avoid extravasation when administering IV epinephrine—check infusion site frequently and treat extravasation with phentolamine 5-10 mg infiltrated locally 2
  • Do not assume sulfite allergy contraindicates epinephrine use—epinephrine should still be used for life-threatening anaphylaxis even in sulfite-sensitive patients 2
  • Monitor for biphasic reactions—up to 20% of anaphylaxis cases may have recurrent symptoms 4-12 hours after initial resolution, necessitating prolonged observation 1

References

Guideline

Anaphylaxis Management in Bee Sting Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Premedication Strategies for Preventing Drug Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Premedication Guidelines for CT Contrast Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hypersensitivity Reactions to Biologicals: from Bench to Bedside.

Current treatment options in allergy, 2020

Research

Diagnosis and management of drug hypersensitivity reactions.

The Journal of allergy and clinical immunology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.